Heping Wang
Affiliations: | Bioinformatics and Computational Biology | UT MD Anderson Cancer Center |
Google:
"Heping Wang"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Yan G, Luna A, Wang H, et al. (2022) BET inhibition induces vulnerability to MCL1 targeting through upregulation of fatty acid synthesis pathway in breast cancer. Cell Reports. 40: 111304 |
Zhao M, Scott S, Evans KW, et al. (2021) Combining neratinib with CDK4/6, mTOR and MEK inhibitors in models of HER2-positive cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
Luna A, Wang H, Babur O, et al. (2019) Abstract 3820: Discovery of adaptive resistance pathways and anti-resistance combination therapies from phosphoproteomic data using graphical models Cancer Research |
Lynce F, Blackburn MJ, Cai L, et al. (2017) Characteristics and outcomes of breast cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase I clinical trials. Breast Cancer Research and Treatment |